Template:General anesthetics: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
m Add WHO-EM essential status to Midazolam, Diazepam & Lorazepam |
||
(22 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name |
| name = General anesthetics |
||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
||
| title = |
| title = [[General anaesthetic|General anesthetic]]s ([[ATC code N01#N01A|N01A]]) |
||
|listclass = hlist |
| listclass = hlist |
||
| groupstyle = background: LemonChiffon |
|||
| group1 = [[Inhalational |
| group1 = [[Inhalational anesthetic|Inhalation]]al |
||
| |
| list1 = |
||
* [[Chloroethane|Chloroethane (ethyl chloride)]]<sup>‡</sup> |
|||
* [[Chloroform]]<sup>‡</sup> |
* [[Chloroform]]<sup>‡</sup> |
||
* [[Cyclopropane]]<sup>‡</sup> |
* [[Cyclopropane]]<sup>‡</sup> |
||
Line 17: | Line 15: | ||
* [[Fluroxene]]<sup>‡</sup> |
* [[Fluroxene]]<sup>‡</sup> |
||
* [[Halothane]]<sup>#</sup> |
* [[Halothane]]<sup>#</sup> |
||
* [[Isoflurane]] |
* [[Isoflurane]]<sup>#</sup> |
||
* [[Methoxyflurane]] |
* [[Methoxyflurane]] |
||
* [[Methoxypropane]]<sup>‡</sup> |
* [[Methoxypropane]]<sup>‡</sup> |
||
Line 23: | Line 21: | ||
* [[Sevoflurane]] |
* [[Sevoflurane]] |
||
* [[Trichloroethylene]]<sup>‡</sup> |
* [[Trichloroethylene]]<sup>‡</sup> |
||
* [[Vinyl ether]]<sup>‡</sup> |
* [[Divinyl ether|Vinyl ether]]<sup>‡</sup> |
||
* [[Xenon]] |
* [[Xenon]] |
||
| group2 = [[ |
| group2 = [[General anaesthetic#Injection|Injection]] |
||
| |
| list2 = {{Navbox|child |
||
| groupstyle = background-color: LemonChiffon |
|||
⚫ | |||
| list1 = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| |
| group1 = [[Phenols]] |
||
| list1 = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| list2 = |
|||
*[[Amobarbital]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
*[[Thiamylal]] |
|||
⚫ | |||
⚫ | |||
| group3 = [[Benzodiazepine|Benzodiazepines]] |
|||
| list3 = |
|||
⚫ | |||
*[[Diazepam]]<sup>#</sup> |
|||
*[[Lorazepam]]<sup>#</sup> |
|||
*[[Remimazolam]] |
|||
⚫ | |||
| list4 = |
|||
* [[Morphine]]<sup>#</sup> |
|||
* [[Oxycodone]] |
|||
* [[Anileridine]]<sup>‡</sup> |
* [[Anileridine]]<sup>‡</sup> |
||
* [[Embutramide]]<sup>‡</sup> |
|||
* [[Fentanyl]] |
* [[Fentanyl]]<sup>#</sup> |
||
⚫ | |||
* [[Phenoperidine]] |
* [[Phenoperidine]] |
||
* [[Remifentanil]] |
* [[Remifentanil]]÷ |
||
* [[Sufentanil]] |
* [[Sufentanil]] |
||
| |
| group5 = [[Arylcyclohexylamine]]s |
||
| list5 = |
|||
* [[Esketamine]] |
* [[Esketamine]] |
||
* [[Ketamine]]<sup>#</sup> |
* [[Ketamine]]<sup>#</sup> |
||
Line 54: | Line 70: | ||
* [[Tiletamine]] |
* [[Tiletamine]] |
||
| group6 = [[Neurosteroid|Neuroactive steroids]] |
|||
⚫ | |||
| list6 = |
|||
* [[Alfadolone]] |
* [[Alfadolone]] |
||
* [[Alfaxalone]] |
* [[Alfaxalone]] |
||
⚫ | |||
⚫ | |||
* [[Hydroxydione]] |
* [[Hydroxydione]] |
||
* [[gamma-Hydroxybutyric acid|GHB]] |
|||
* [[Metomidate]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| group7 = Others |
|||
⚫ | |||
| list7 = |
|||
⚫ | |||
* [[Propanidid]]<sup>‡</sup> |
|||
⚫ | |||
⚫ | |||
| list3 = |
|||
| belowstyle = background: transparent; padding: 0px; |
|||
⚫ | |||
| below = {{Central nervous system navs}} |
|||
}}<noinclude> |
}}<noinclude> |
||
{{collapsible option}} |
{{collapsible option}} |
||
[[Category: |
[[Category:Drug templates by ATC]] |
||
[[Category:Drug_templates by ATC]] |
|||
<!--fr:Modèle:Analgésique--> |
|||
</noinclude> |
</noinclude> |
Latest revision as of 21:55, 4 February 2024
This template's initial visibility currently defaults to autocollapse
, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state=
parameter may be used:
{{General anesthetics|state=collapsed}}
will show the template collapsed, i.e. hidden apart from its title bar.{{General anesthetics|state=expanded}}
will show the template expanded, i.e. fully visible.